Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats
about
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesPotential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamineσ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-AdministrationRegulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamineA role for sigma receptors in stimulant self-administration and addiction.Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve RatsBlockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists.Differential Roles for Dopamine D1-Like and D2-Like Receptors in Mediating the Reinforcing Effects of Cocaine: Convergent Evidence from Pharmacological and Genetic Studies.Trace Amine-Associated Receptor Type 1 as A Target for The Development of Treatments for Stimulant Abuse.Preclinical Efficacy of Novel Vesicular Monoamine Transporter 2 Inhibitors as Antagonists of d-Methamphetamine Self-Administration in Rats.Cocaine Antagonists; Studies on Cocaine Self-Administration.Medications Discovery: Importance of Assessment of Drug Self Administration Dose-Effect Curves.Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist.Importance of Substrate-Coupled Proton Antiport by the Vesicular Monoamine Transporter in the Actions of Amphetamines in Drosophila Brain.2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Effects of environmental enrichment on self-administration of the short-acting opioid remifentanil in male rats.The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents.Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons.The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats.Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.Dopamine Transporter Dynamics of -Substituted Benztropine Analogs with Atypical Behavioral Effects
P2860
Q26829749-CBFCA555-50D3-4FE1-8D63-3C02F6286253Q28066691-457327E0-3B69-4693-AFB1-BC29A4C10D8DQ28392148-99692CF3-FC43-493F-9B52-7DAFCDE3CEA1Q33754479-D1936748-9EEB-48EC-8ABD-CCFF74AA26A7Q34673305-56C839D2-A92A-4B41-82AF-AF31D55DE598Q35160057-46C432C5-3A7A-405C-B1B3-AABBCDAB6ADDQ36655919-B7B398D7-D6A3-47F2-B87A-0FCC2D8396CDQ37058585-0E213230-5931-44DF-B7F1-A86E259DED5BQ37062588-52072AA1-DB5E-4CB4-898F-022FF50AA801Q37064869-7EC0D8B1-1549-454D-8D11-3A628BF55A80Q37064873-8B91C5C6-C5CD-4590-B5E0-610763249A0CQ37068964-AC0A5AD0-6A81-416C-9973-2BB2C40D0E74Q37073018-A62942C0-0A7C-4735-A451-6F8B2C745B61Q37082881-789F6C79-3EA8-4CF2-BB38-D5B2589CD2D1Q37405350-BAE18AE9-D7C2-4ED0-A9CC-23BE4C17B17FQ37619367-FCD0795F-5C63-40B9-8BE8-9587B0C89B5EQ37707743-52229CF1-0F29-45BD-B35B-9B4FCF8619C9Q39034288-E506707F-C83E-4E10-B53F-C84DAB4123DAQ41997501-3B5A1BE0-4F92-4014-82DD-1127C8CC8B09Q47109201-354CD738-34E8-4CBD-8A53-5A72C40F6A12Q47344389-BA85917D-A162-45EB-B705-7A5E4DA0B3FCQ47825128-42EDAB51-7D7F-45C3-91D5-391DADB671BBQ47845016-9219256A-193B-4AE0-8E68-C3304FB0BDE9Q47950931-D540D300-5538-48C7-9144-EEE309F5E237Q50023810-4C4E470F-D8AC-47EB-B69D-D22CF1DA6730Q51175465-1FAB7103-F7E7-4165-ACC8-5E936C9A798DQ58777932-E5818975-1BB7-4E52-8FFF-6487195D50C7
P2860
Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Preclinical efficacy of N-subs ...... ne self-administration in rats
@ast
Preclinical efficacy of N-subs ...... ne self-administration in rats
@en
Preclinical efficacy of N-subs ...... ne self-administration in rats
@nl
type
label
Preclinical efficacy of N-subs ...... ne self-administration in rats
@ast
Preclinical efficacy of N-subs ...... ne self-administration in rats
@en
Preclinical efficacy of N-subs ...... ne self-administration in rats
@nl
prefLabel
Preclinical efficacy of N-subs ...... ne self-administration in rats
@ast
Preclinical efficacy of N-subs ...... ne self-administration in rats
@en
Preclinical efficacy of N-subs ...... ne self-administration in rats
@nl
P2093
P2860
P356
P1476
Preclinical efficacy of N-subs ...... ne self-administration in rats
@en
P2093
Paul L Soto
Stephen J Kohut
Takato Hiranita
Theresa A Kopajtic
P2860
P304
P356
10.1124/JPET.113.208264
P407
P577
2013-11-05T00:00:00Z